Schmidt M, Mattern S, Singer S, Schulze M, et al. NOTCH3 missense mutations as predictor of long-term response to gemcitabine in a patient with epithelioid hemangioendothelioma. J Cancer Res Clin Oncol 2023;149:6753-6757.
PMID: 36749424